Health Research and Policy

Research in Progress Seminar (RIP)

Date: October 30, 2013
Time: 4:00 - 5:00 pm
Location: CHP/PCOR Conference Room
117 Encina Commons
Speaker: Mark Hlatky, MD
Professor of Health Research and Policy and of Medicine (Cardiovascular Medicine)
Title: Are Drug Eluting Stents for Multivessel Coronary Disease as Good as CABG?


The comparative effectiveness of coronary revascularization procedures (CABG or PCI) to treat multivessel coronary disease has been assessed using both randomized trials and observational studies. PCI practice continues to evolve, however, because of new coronary stent technology. Drug-eluting stents (DES) were quickly and almost universally adopted soon after their introduction in 2003, and many cardiologists believe that DES use reduces mortality and myocardial infarction (MI). This, along with other improvements in heart disease treatments, make comparison of CABG and PCI a moving target. I will describe ongoing work that examines whether adoption of DES for PCI has changed the comparative effectiveness of CABG and PCI for death and MI, as well as repeat coronary procedures.

Please note: All research in progress seminars are off-the-record. Any information about methodology/press release and/or results are embargoed until publication.
Back to RIP

Footer Links: